Cultivated food

CellulaREvolution Edges Closer To Commercial Launch With New $2.38 Million Pre-Series A Investment Round

Cell cultivation technology

CellulaREvolution has announced the closure of a new funding round. Having netted £1.75 million in a pre-Series A, the British biotech intends to accelerate the development of its continuous cell cultivation technology. This will be used to usher in cultivated meat as a viable and affordable product, within a reasonable timescale. Hong Kong-based Happiness Capital led the investment round, with Allusion One also participating. 

Photo by CellulaREvolution.

New funding follows on from a seed investment round in January 2021 which saw £1.2 million raised. R&D continuation, plus a bolstered commercial team are top priorities for CellulaREvolution. The latter will provide support when in-house bioreactor technology is released to market. The tech will provide a potential solution to cultivated meat manufacturers who struggle to reach price parity with conventional products. It has biologics and cell therapeutics potential as well, allowing for future broad market share.

Green Queen

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button